All News

Concurrent chemoradiotherapy with proton radiation can reduce short-term side effects that caused unplanned hospitalizations, with similar disease-free and overall survival, compared with photon radiation.

The pivotal phase 3 GRAVITAS-301 study – designed to evaluate itacitinib in combination with corticosteroids in patients with treatment-naïve acute graft-versus-host disease – failed to meet its primary endpoint of improving overall response rates.

Patients with previously untreated locally advanced or metastatic urothelial carcinoma treated with Bavencio and best supportive care as a first-line maintenance therapy experienced significantly longer survival.

Treatment with a CAR-T cell therapy showed promise in patients with mantle cell lymphoma, potentially leading to a new option for a group of individuals who have exhausted other options.

Recurrence isn’t the only long-term complication cancer patients may face but understanding these potential challenges can help you mitigate many problems beforehand.

Researchers found that combining family history and genetic risk scores to determine inherited risk for prostate cancer could personalize screening strategies for men.

Those with follicular lymphoma and chronic lymphocytic leukemia who were treated with Zydelig in the clinical setting experienced less favorable outcomes, compared with those treated in a clinical trial.

Reflecting on the lessons learned from the trauma of living with a stage four cancer diagnosis.

From Alex Trebek talking chemotherapy for his pancreatic cancer and his final “Jeopardy!” show to the passing of World Series Legend Don Larsen, here’s what is making headlines in the cancer space this week.

This two-time cancer survivor writes to-do lists and weeds out her cancer clutter and home after the New Year, resulting in less physical and mental clutter, and less worry.

A modified citrus pectin, naturally found in the peel of citrus fruits, showed continued benefit among men with prostate cancer.

We remember big events like births, deaths, marriages and holidays, but sometimes it's the little acts of kindness we remember the most.

The American Cancer Society launched a video series to offer support for caregivers to address their questions and concerns throughout their loved one’s cancer journey.

Here is a list of the recent trial initiations that occurred within the cancer space in December.

A breast cancer and melanoma survivor encourages looking forward to the New Year.

Each new year, many make resolutions for change. For the person with cancer, resolutions are important but also need to be realistic.

The Food and Drug Administration approved the first PARP inhibitor for the maintenance treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated metastatic pancreatic adenocarcinoma.

One survivor reflects on life after cancer on "cannoli Monday."

As 2019 comes to a close, take a read through CURE®’s top stories of the year.

One male breast cancer survivor reflects on revolutionary developments from the San Antonio Breast Cancer Symposium.

Sometimes the imperfections in life can bring an unexpected beauty. A famous mystery author explores this idea.

The Food and Drug Administration’s accelerated approval of Padcev offers patients with advanced bladder cancer a potential standard of care.

An improved app sends clinical trials straight to the phone of this patient with breast cancer (and she can forward them right to her doctor).

Take a look back at the top 10 podcasts of 2019 – and be sure to subscribe so you don’t miss an episode in 2020.

If you’ve experienced neuropathy, you know what it entails.

A diagnosis of breast cancer can cause a person to become very fearful especially when the future holds so many unknowns, but it’s not healthy to live under an umbrella of fear. In this article, survivor, Bonnie Annis, shares her experience.

The author uses a well-known story about landing in another country to explain cancer journeys.

A two-time cancer survivor suggests simplifying the holidays when coping with cancer.